论文部分内容阅读
目的观察磷酸肌酸钠治疗小儿病毒性心肌炎的临床疗效。方法将76例病毒性心肌炎住院患儿随机分为治疗组40例,对照组36例,对照组采用常规综合治疗,治疗组加用磷酸肌酸静脉滴注,观察两组患儿的临床症状、心电图、心肌酶谱等指标变化。结果治疗组总有效率(92.5%)明显高于对照组(63.9%),经统计学处理,差异有统计学意义(P<0.05)结论磷酸肌酸钠治疗病毒性心肌炎可提高疗效,无明显不良反应。
Objective To observe the clinical efficacy of sodium creatine phosphate in the treatment of viral myocarditis in children. Methods A total of 76 children with viral myocarditis were randomly divided into treatment group (n = 40) and control group (n = 36). The control group was treated with conventional comprehensive therapy. The treatment group was treated with intravenous phosphate creatine phosphate (PHT), and the clinical symptoms, ECG, myocardial enzymes and other indicators change. Results The total effective rate (92.5%) in the treatment group was significantly higher than that in the control group (63.9%), and the difference was statistically significant (P <0.05). Conclusions The treatment of viral myocarditis by sodium creatine phosphate can improve the curative effect without significant Adverse reactions.